HYDROMORPHON
Anatomic Stage IA Breast Cancer AJCC v8
Ohio State University Comprehensive Cancer CenterSmall moleculePhase 2/3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
12 Active assets in the Anatomic Stage IA Breast Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Tianjin Medical University Cancer Institute and Hospital | Phase 4 | BBB |
Benadryl Ohio State University Comprehensive Cancer Center | Phase 2/3 | BB |
Dfn-15 OHSU Knight Cancer Institute | Phase 2 | B |
Famotidine Ohio State University Comprehensive Cancer Center | Phase 2/3 | B |
FENTANYL Ohio State University Comprehensive Cancer Center | Phase 2/3 | B |
View all 24 →
Same molecule, other indications
HYDROMORPHON is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →